meRfi®-GM
TLR2 / TLR6 Heterodimer (TLR2/TLR6)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The agonists (e.g., atypical LPS, Lipoprotein , Lipopeptide, Lipoarabinomannan , Lipoteichoic acid , Modulin , Porin , Peptidoglycan, Zymosan, Trypanosoma cruzi GIPLs, Glycolipids (GIPLs)) lead (left) to dimerization (= TLR2 / TLR6 heterodim…
References (Sources)
- Association of a common TLR-6 polymorphism with coronary artery disease implications for healthy ageing?
- Modulation of atherosclerosis in mice by Toll-like receptor 2
- Targeting Toll-like receptors for cancer therapy.
- The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
- TLR2 looks at lipoproteins
- Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women
- Ubiquitin signalling in the NF-κB pathway